Observational Study With PASCALLERG ® in Patients With Hay Fever

Study Overview
=================
Brief Summary
-----------------
The aim of this observational study is to document the therapeutic use of PASCALLERG ® for hay fever. Based on the survey is a decrease in disease-specific symptoms when taking PASCALLERG ® over a period of 4 weeks will be documented. In addition to the compatibility can be assessed.

Detailed Description
-----------------
There are documented male and female patients over the age of one year who suffer from hay fever. The traetment time is about a period of 4 weeks with PASCALLERG® tablets.

Official Title
-----------------
Observational Study With PASCALLERG ® in Patients With Hay Fever

Conditions
-----------------
Hay Fever

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: hay fever Exclusion Criteria: Lactose intolerance and / or Chromium hypersensitivity

Ages Eligible for Study
-----------------
Minimum Age: 1 Year

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| PASCALLERG® tablets in patients with hay fever<br>Patients with lactose intolerance and / or chromium hypersensitivity are excluded from the observational study. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Efficacy of Pascallerg | Request of Efficacy using a 4-stage scale (very good efficacy, good efficacy, moderate efficacy, no efficacy) | appr. 4 weeks after baseline (after appr. 4 weeks of treatment) | 
| Tolerability of Pascallerg | Request of Tolerability using a 2-stage scale (very good tolerability, bad tolerability) | app. 4 weeks after baseline (treatment app. for 4 weeks) | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Numerical Rating Scale Well Beeing (Pre- Post) | Influence of allergy on the general well-being (scale from 0-no influence to 10 strong influence) | Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline) | 
| Change of Symptom Dry Eyes (Pre- Post) | Request Scale (0=not present, 1=mild, 2=moderate, 3=strong) | Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline) | 
| Change of Symptom Itching Eyes (Pre- Post) | Request Scale (0=not present, 1=mild, 2=moderate, 3=strong) | Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline) | 
| Change of Symptom Burning Eyes (Pre-post) | Request Scale (0=not present, 1=mild, 2=moderate, 3=strong) | Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline) | 
| Change of Symptom Bronchial Complaints (Pre-post) | Request Scale (0=not present, 1=mild, 2=moderate, 3=strong) | Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline) | 
| Change of Symptom Sneezing (Pre-post) | Request Scale (0=not present, 1=mild, 2=moderate, 3=strong) | Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline) | 
| Change of Symptom Rhinitis (Pre-post) | Request Scale (0=not present, 1=mild, 2=moderate, 3=strong) | Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline) | 
| Change of Symtom Fatigue / Tiredness | Request Scale (0=not present, 1=mild, 2=moderate, 3=strong) | Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline) | 
| Change of Symptom Headache (Pre-post) | Request Scale (0=not present, 1=mild, 2=moderate, 3=strong) | Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline) | 
| Change of Symptom Tearing Eyes (Pre-post) | Request Scale (0=not present, 1=mild, 2=moderate, 3=strong) | Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline) | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Hay fever, Pascallerg